Home » Topics » Hematologic, BioWorld Science

Hematologic, BioWorld Science
RSS

NovoSeven Spanish introduction imminent

May 17, 1996

Hokuriku TxA2 antagonist selected for evaluation

May 17, 1996

SKB discloses fibrinogen and vitronectin antagonists in patent literature

May 17, 1996

Fibrinogen antagonist from natrual source reported by Takeda

May 17, 1996

Argatroban enters phase III for HIT, HITTS

May 17, 1996

Active-site thrombin inhibitors reported by BMS

May 17, 1996

Teijin claims anticoagulant peptides

May 17, 1996

LY-329186 + aspirin effective in canine thrombosis model

May 10, 1996

Platelet antiaggregatory activity seen with Asahi's L-103

May 10, 1996

Taisho research into fibrinogen antagonists

May 10, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 4, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...